Northwestern Mutual Wealth Management
BOLT icon

Northwestern Mutual Wealth Management’s Bolt Biotherapeutics BOLT Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20
Closed -$512 – 3301
2023
Q2 		$512 Hold
20
– – ﹤0.01% 3175
2023
Q1 		$556 Hold
20
– – ﹤0.01% 3096
2022
Q4 		$520 Hold
20
– – ﹤0.01% 3127
2022
Q3 		$1K Hold
20
– – ﹤0.01% 2955
2022
Q2 		$1K Hold
20
– – ﹤0.01% 3003
2022
Q1 		$1K Hold
20
– – ﹤0.01% 2970
2021
Q4 		$2K Hold
20
– – ﹤0.01% 2935
2021
Q3 		$5K Buy
+20
New +$5.65K ﹤0.01% 2653

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northwestern Mutual Wealth Management's BOLT Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Bolt Biotherapeutics (BOLT) in Q3 2023, closing a stake of 20 shares — an estimated $512 sold.

Northwestern Mutual Wealth Management first reported a position in BOLT in Q3 2021 and held it in 8 quarters. The position peaked at $5K in Q3 2021. 34 funds tracked by Wall St. Rank hold BOLT as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Bolt Biotherapeutics position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 20 Bolt Biotherapeutics shares in Q3 2023, an estimated $512.
  • Northwestern Mutual Wealth Management first reported a position in Bolt Biotherapeutics in Q3 2021 and held it in 8 quarters.
  • Northwestern Mutual Wealth Management's Bolt Biotherapeutics position peaked at $5K in Q3 2021.
  • 34 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.